FOXO3 and coronary artery disorder: In 165 patients with stable coronary heart disease, moderate aerobic training enhanced epoxy-eicosatrienoic acids, activated the FoxO3a/Sirt6 axis, suppressed PCSK9, and ultimately lowered LDL-C despite ongoing statin therapy (Hu et al., 2025).